Origin Therapeutics Holdings (XCNQ:ORIG) Total Stockholders Equity : C$3.08 Mil (As of Jun. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Total Stockholders Equity?

Origin Therapeutics Holdings's Total Stockholders Equity for the quarter that ended in Jun. 2023 was C$3.08 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Origin Therapeutics Holdings's Book Value per Share for the quarter that ended in Jun. 2023 was C$0.05. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Origin Therapeutics Holdings's Debt-to-Equity for the quarter that ended in Jun. 2023 was 0.00.

Origin Therapeutics Holdings Total Stockholders Equity Historical Data

The historical data trend for Origin Therapeutics Holdings's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Total Stockholders Equity Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Total Stockholders Equity

6.88

5.43

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Total Stockholders Equity	Get a 7-Day Free Trial				5.98	5.43	5.30	3.15	3.08

Origin Therapeutics Holdings (XCNQ:ORIG) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Origin Therapeutics Holdings's Book Value per Share for the quarter that ended in Jun. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(3.081	-	0)	/	56.563
	=	0.05

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Origin Therapeutics Holdings's Debt-to-Equity for the quarter that ended in Jun. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	3.081
	=	0.00

Origin Therapeutics Holdings Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.